These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21125465)

  • 1. Clinical trial of nicardipine prolonged-release implants for preventing cerebral vasospasm: multicenter cooperative study in Tokyo.
    Kasuya H
    Acta Neurochir Suppl; 2011; 110(Pt 2):165-7. PubMed ID: 21125465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of nicardipine prolonged-release implants after clipping for preventing cerebral vasospasm: from laboratory to clinical trial.
    Kasuya H
    Acta Neurochir Suppl; 2013; 115():41-4. PubMed ID: 22890641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicardipine prolonged-release implants for preventing cerebral vasospasm after subarachnoid hemorrhage: effect and outcome in the first 100 patients.
    Krischek B; Kasuya H; Onda H; Hori T
    Neurol Med Chir (Tokyo); 2007 Sep; 47(9):389-94; discussion 394-6. PubMed ID: 17895611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of nicardipine prolonged-release implants for preventing vasospasm in humans.
    Kasuya H; Onda H; Takeshita M; Okada Y; Hori T
    Stroke; 2002 Apr; 33(4):1011-5. PubMed ID: 11935053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of nicardipine prolonged release implants (NPRI) in microsurgical clipping after aneurysmal subarachnoid haemorrhage: comparison with endovascular treatment.
    Schneider UC; Dreher S; Hoffmann KT; Schmiedek P; Kasuya H; Vajkoczy P
    Acta Neurochir (Wien); 2011 Nov; 153(11):2119-25. PubMed ID: 21858650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does intrathecal nicardipine for cerebral vasospasm following subarachnoid hemorrhage correlate with reduced delayed cerebral ischemia? A retrospective propensity score-based analysis.
    Sadan O; Waddel H; Moore R; Feng C; Mei Y; Pearce D; Kraft J; Pimentel C; Mathew S; Akbik F; Ameli P; Taylor A; Danyluk L; Martin KS; Garner K; Kolenda J; Pujari A; Asbury W; Jaja BNR; Macdonald RL; Cawley CM; Barrow DL; Samuels O
    J Neurosurg; 2022 Jan; 136(1):115-124. PubMed ID: 34087804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicardipine pellets for the prevention of cerebral vasospasm.
    Thomé C; Seiz M; Schubert GA; Barth M; Vajkoczy P; Kasuya H; Schmiedek P
    Acta Neurochir Suppl; 2011; 110(Pt 2):209-11. PubMed ID: 21125473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of intrathecal nicardipine for aneurysmal subarachnoid hemorrhage-induced cerebral vasospasm.
    Ehtisham A; Taylor S; Bayless L; Samuels OB; Klein MW; Janzen JM
    South Med J; 2009 Feb; 102(2):150-3. PubMed ID: 19139684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cilostazol on cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a multicenter prospective, randomized, open-label blinded end point trial.
    Senbokuya N; Kinouchi H; Kanemaru K; Ohashi Y; Fukamachi A; Yagi S; Shimizu T; Furuya K; Uchida M; Takeuchi N; Nakano S; Koizumi H; Kobayashi C; Fukasawa I; Takahashi T; Kuroda K; Nishiyama Y; Yoshioka H; Horikoshi T
    J Neurosurg; 2013 Jan; 118(1):121-30. PubMed ID: 23039152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage.
    Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Xu B; Wang R
    Neurol Med Chir (Tokyo); 2006 Sep; 46(9):421-8. PubMed ID: 16998274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage.
    Kasuya H; Onda H; Sasahara A; Takeshita M; Hori T
    Neurosurgery; 2005 May; 56(5):895-902; discussion 895-902. PubMed ID: 15854236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study.
    Barth M; Capelle HH; Weidauer S; Weiss C; Münch E; Thomé C; Luecke T; Schmiedek P; Kasuya H; Vajkoczy P
    Stroke; 2007 Feb; 38(2):330-6. PubMed ID: 17185636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial of high-dose intravenous nicardipine in aneurysmal subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study.
    Haley EC; Kassell NF; Torner JC
    J Neurosurg; 1993 Apr; 78(4):537-47. PubMed ID: 8450326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A postmarketing surveillance study of fasudil treatment after aneurysmal subarachnoid hemorrhage.
    Suzuki Y; Shibuya M; Satoh S; Sugimoto Y; Takakura K
    Surg Neurol; 2007 Aug; 68(2):126-31; discussion 131-2. PubMed ID: 17586012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of intraarterial administration of fasudil hydrochloride for preventing symptomatic vasospasm after subarachnoid hemorrhage.
    Saito A; Inoue M; Kon H; Imaruoka S; Basaki K; Midorikawa H; Sasaki T; Nishijima M
    Acta Neurochir Suppl; 2015; 120():297-301. PubMed ID: 25366640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of intrathecal nicardipine on cerebral vasospasm in non-traumatic subarachnoid hemorrhage: a systematic review.
    Stuart D; Christian R; Uschmann H; Palokas M
    JBI Database System Rev Implement Rep; 2018 Oct; 16(10):2013-2026. PubMed ID: 30335041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of intraventricular nicardipine prolonged release implants in patients following aneurysmal subarachnoid haemorrhage.
    Barth M; Pena P; Seiz M; Thomé C; Muench E; Weidauer S; Hattingen E; Kasuya H; Schmiedek P
    Br J Neurosurg; 2011 Dec; 25(6):677-83. PubMed ID: 21344979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Basic research and treatment for cerebral vasospasm after subarachnoid hemorrhage: the present and future prospects].
    Nishizawa S; Zhang JH
    No Shinkei Geka; 2008 Feb; 36(2):121-33. PubMed ID: 18265695
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemodynamic management and outcome of patients treated for cerebral vasospasm with intraarterial nicardipine and/or milrinone.
    Schmidt U; Bittner E; Pivi S; Marota JJ
    Anesth Analg; 2010 Mar; 110(3):895-902. PubMed ID: 20185665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.